<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Summary of anesthetic considerations based on the 2016 Brain Trauma Foundation Guidelines for the Management of Severe Traumatic Brain Injury</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Summary of anesthetic considerations based on the 2016 Brain Trauma Foundation Guidelines for the Management of Severe Traumatic Brain Injury</h1>
<div class="graphic"><div class="figure"><div class="ttl">Summary of anesthetic considerations based on the 2016 Brain Trauma Foundation Guidelines for the Management of Severe Traumatic Brain Injury</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">Parameter/modality</td> <td class="subtitle1">Recommendation/comment</td> <td class="subtitle1">Anesthetic consideration</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Treatment phase</td> </tr> <tr class="divider_bottom"> <td class="indent1">Hyperosmolar therapy</td> <td> <ul> <li>Hyperosmolar therapy with mannitol or hypertonic saline may lower intracranial pressure, but there is insufficient evidence to support the use of one rather than the other. </li> </ul> </td> <td>Hyperosmolar agents are often required preoperatively and intraoperatively. When using mannitol, the anesthetist must be aware of fluid shifts; hypovolemia in a patient with concurrent hemorrhagic shock can be exacerbated.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Cerebrospinal fluid drainage</td> <td> <ul> <li>An EVD zeroed at the midbrain with continuous drainage of CSF may be considered to lower ICP; this may be more effective than intermittent use. </li> <li>The use of an EVD to lower ICP in patients with an initial GCS &lt;6 during the first 12 hours of injury may be considered. </li> </ul> </td> <td>Continuous monitoring requires constant intraoperative vigilance; excessive drainage can lead to brain herniation.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Ventilation therapies</td> <td> <ul> <li>Hyperventilation is recommended as a temporizing measure for the reduction of elevated ICP. </li> <li>Hyperventilation should be avoided during the first 24 hours after injury when CBF is often critically reduced. </li> <li>Prolonged hyperventilation with a PaCO<sub>2</sub> of 25 mmHg or less is not recommended. </li> </ul> </td> <td>The target PaCO<sub>2</sub> is 35 to 45 mmHg; PaCO<sub>2</sub> is a powerful determinant of CBF. Low PaCO<sub>2</sub> levels result in low CBF and cerebral ischemia whereas high PaCO<sub>2</sub> levels can result in cerebral hyperemia and high ICP.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Anesthetics, analgesics, sedatives</td> <td> <ul> <li>The use of barbiturates to induce burst suppression as measured by EEG as prophylaxis against an elevated ICP is not recommended. </li> <li>High dose barbiturate administration is recommended to control elevated ICP refractory to maximum standard medical and surgical treatment. </li> <li>Propofol is recommended to help control ICP, but caution is required as high-dose propofol is associated with significant morbidity. </li> </ul> </td> <td> <p>Patients with ICP elevation refractory to standard medical treatment may present to the operating room on a barbiturate infusion.</p> High dose propofol should be avoided.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Steroids</td> <td> <ul> <li>The use of steroids is not recommended. High-dose methylprednisolone is associated with increased mortality. </li> </ul> </td> <td>Steroids are contraindicated and should not be administered in the OR.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Infection prophylaxis</td> <td> <ul> <li>General critical care protocols and practices should be followed to prevent ventilator-associated pneumonia; periprocedural antibiotics for intubation are no longer recommended. </li> </ul> </td> <td>Antibiotics before intubation are not required (a change from the previous 3rd edition guidelines).</td> </tr> <tr class="divider_bottom"> <td class="indent1">Seizure prophylaxis</td> <td> <ul> <li>Early (within seven days of injury) administration of phenytoin is recommended to decrease the incidence of post-traumatic seizures. </li> <li>There is insufficient evidence to recommend levetiracetam (Keppra) over phenytoin regarding efficacy in preventing post-traumatic seizures. </li> </ul> </td> <td> <p>Seizure prophylaxis with phenytoin is often initiated in the operating room. Intravenous fosphenytoin or levetiracetam should be considered instead of phenytoin due to risks associated with extravasation of phenytoin.</p> Active seizures should be treated according to the standard of care (ie, midazolam or lorazepam).</td> </tr> <tr class="divider_bottom"> <td class="indent1">Prophylactic hypothermia</td> <td> <ul> <li>Not recommended to improve outcomes in patients with diffuse injury. </li> </ul> </td> <td>Temperature monitoring for TBI patients is mandatory; normothermia should be maintained.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Monitoring phase</td> </tr> <tr class="divider_bottom"> <td class="indent1">Intracranial pressure monitoring</td> <td> <ul> <li>Management of severe TBI patients using information from ICP monitoring is recommended to reduce post-injury mortality. </li> </ul> </td> <td>Although not supported by evidence meeting current standards, ICP should be measured in TBI patients with a GCS of 3 to 8 and an abnormal CT scan (ie, a scan that reveals hematomas, contusions, swelling, herniation, or compressed basal cisterns). ICP monitoring may also be indicated in severe TBI patients with a normal CT scan who are older than 40 years of age, have hypotension (SBP &lt;90 mmHg), or exhibit unilateral or bilateral motor posturing.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Cerebral perfusion pressure monitoring</td> <td> <ul> <li>CPP monitoring is recommended to decrease mortality. </li> </ul> </td> <td>CPP is proportional to the gradient between MAP and mean ICP; MAP can be modulated directly by the anesthetist (ie, with vasopressors, fluids) and requires close monitoring (ie, with arterial catheter) and treatment in the operating room.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Advanced cerebral monitoring</td> <td> <ul> <li>Jugular bulb monitoring of arteriovenous oxygen content difference may be considered. </li> <li>Brain tissue oxygen monitoring is no longer recommended due to insufficient evidence. </li> </ul> </td> <td>Anesthetists should be aware of the presence of jugular bulb monitors, and how to correctly interpret the information provided by these devices.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Thresholds</td> </tr> <tr class="divider_bottom"> <td class="indent1">Blood pressure</td> <td> <ul> <li>Maintaining SBP ≥100 mmHg for patients 50 to 69 years old or at ≥110 mmHg for patients 15 to 49 or &gt;70 years old may be considered to decrease mortality and improve outcomes. </li> </ul> </td> <td>Monitoring blood pressure (ie, arterial catheter) and avoiding hypotension in patients with severe TBI is a major perioperative goal.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Intracranial pressure</td> <td> <ul> <li>Treatment for ICP greater than 22 mmHg is recommended because values above this level are associated with increased mortality. </li> </ul> </td> <td>In practice, a combination of ICP values, clinical exam, and brain CT findings are required to make management decisions.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Cerebral perfusion pressure</td> <td> <ul> <li>The recommended CPP value is 60 to 70 mmHg. </li> </ul> </td> <td>The exact threshold for CPP is unclear, and depends on the patient's autoregulatory status.</td> </tr> <tr> <td class="indent1">Advanced monitoring</td> <td> <ul> <li>A jugular venous saturation &lt;50% may be a threshold to avoid in order to reduce mortality and improve outcomes. </li> </ul> </td> <td>Anesthetists should be aware of the presence of jugular bulb monitors, and how to correctly interpret the information provided by these devices.</td> </tr> </tbody></table></div><div class="graphic_footnotes">EVD: external ventricular device; CSF: cerebrospinal fluid; ICP: intracranial pressure; GCS: Glascow coma scale; CBF: cerebral blood flow; EEG: electroencephalogram; OR: operating room; TBI: traumatic brain injury; CT: computerized tomography; SBP: systolic blood pressure; CPP: cerebral perfusion pressure; MAP: mean arterial pressure.</div><div class="graphic_reference">Adapted from: Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery 2017; 80:6.</div><div id="graphicVersion">Graphic 113185 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
